HALF MOON

Preferred Hotels & Resorts Announces 2023 Awards of Excellence and GIFTTS Pineapple Awards Winners

Retrieved on: 
Saturday, May 20, 2023

NEW YORK, May 20, 2023 /PRNewswire-PRWeb/ -- Preferred Hotels & Resorts, the world's largest independent hotel brand, is pleased to announce the winners of its 2023 Preferred Awards of Excellence and GIFTTS Pineapple Awards. The awards were presented yesterday at Half Moon, a member of the brand's Legend Collection in Montego Bay, Jamaica, at the closing ceremony of the 2023 Preferred Global Conference. With the Preferred brand in its 55th year, and the conference theme Heart of Hospitality chosen to convey the collective passion for service shared by attendees, the 2023 awards reflected the brand's long held commitment to independent hotels and turned the spotlight on the sustainability and philanthropic efforts of its member properties.

Key Points: 
  • Preferred Hotels & Resorts, the world's largest independent hotel brand, is pleased to announce the winners of its 2023 Preferred Awards of Excellence and GIFTTS Pineapple Awards.
  • NEW YORK, May 20, 2023 /PRNewswire-PRWeb/ -- Preferred Hotels & Resorts , the world's largest independent hotel brand, is pleased to announce the winners of its 2023 Preferred Awards of Excellence and GIFTTS Pineapple Awards.
  • These awards celebrate exceptional actions in the areas of philanthropy, environment, and community as part of Preferred Hotels & Resorts' GIFTTS program.
  • These awards recognize member hotels that epitomize excellence within the Preferred Hotels & Resorts portfolio of over 650 hotels, resorts, and residences, and inspire the global travel community to pursue #ThePreferredLife.

The Foundry Announces Successful First-In-Human Procedure In Study Of Innovative Transcatheter Mitral Valve Repair Technology

Retrieved on: 
Monday, January 11, 2021

The investigational Half Moon mitral valve repair device, developed through a unique partnership between Medtronic (NYSE:MDT) and The Foundry, is designed to restore function in a diseased mitral valve in patients with severe symptomatic mitral regurgitation (MR), a disease where blood leaks backwards within the heart due to the mitral valve's inability to close properly.

Key Points: 
  • The investigational Half Moon mitral valve repair device, developed through a unique partnership between Medtronic (NYSE:MDT) and The Foundry, is designed to restore function in a diseased mitral valve in patients with severe symptomatic mitral regurgitation (MR), a disease where blood leaks backwards within the heart due to the mitral valve's inability to close properly.
  • "Minimally invasive transcatheter heart valve repair can offer relief from mitral valve regurgitation without the need for traditional open-heart surgery," said Howard Song, M.D., Ph.D., OHSU cardiothoracic surgery division chief, who co-led the procedure.
  • The Half Moon mitral valve repair device is unique from other mitral valve repair technologies in maintaining more natural physiologic functionality of the mitral valve.
  • It is deployed using a transfemoral (through the leg) delivery catheter, which is navigated through the vasculature to the diseased native mitral valve.